Economic Evaluations of Cholesterol-Lowering Drugs Pearl D. GumbsMonique W. M. VerschurenOlaf H. Klungel Review Article 22 September 2012 Pages: 187 - 199
Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases David F. MooreMarkus RiesRaphael Schiffmann Original Research Article 22 September 2012 Pages: 201 - 208
Do Drugs Reduce Utilisation of Other Healthcare Resources? Pierre-Yves CrémieuxPierre OuellettePatrick Petit Original Research Article 22 September 2012 Pages: 209 - 221
Recombinant Erythropoietin for Chemotherapy-Related Anaemia Diego F. OssaAndrew BriggsMark Sculpher Original Research Article 22 September 2012 Pages: 223 - 237
Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients Danielle E. M. BrunenbergGwenn E. C. WetzelsManuela A. Joore Original Research Article 22 September 2012 Pages: 239 - 251
Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada Daniel T. GrimaMelissa F. ThompsonLuc Sauriol Original Research Article 22 September 2012 Pages: 253 - 266